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Abstract 
 Chronic disease is a long-lasting condition that can be controlled but not cured. Owing to the 
portability and continuous action, wearable devices are regarded as promising ways for 
management and rehabilitation of patients with chronic diseases. Although the monitoring 
functions of mobile health care are in full swing, the research direction along wearable therapy 
devices has not been paid with enough attention. The aim of this review paper is to summarize 
recent developments in the field of wearable devices, with particular focus on specific 
interpretations of therapy for chronic diseases including diabetes, heart disease, Parkinson's 
disease, chronic kidney disease and movement disability after neurologic injuries. A brief 
summary on the key enabling technologies allowing for the implementation of wearable 
monitoring and therapy devices is given, such as miniaturization of electronic circuits, data 
analysis techniques, telecommunication strategy and physical therapy etc. For future 
developments, research directions worth of pursuing are outlined. 
 
Keywords: Wearable medical device; Chronic disease management; Continuous monitoring; 
Long-term therapy; Health care.  
1. Introduction 
 With the progresses in science and technology, residents in industrialized cities are now 
living longer, but with multiple complicated health conditions [1]. Clinical operations are also 
increasingly accurate, however, prevalence of chronic disease and aging population begin to 
trouble the healthcare system accompanying rising costs [2,3]. Chronic diseases like diabetes, high 
blood pressure, Parkinson's disease and so forth have limited treatment methods due to 
complicated and confused causes while narrow part of pathologic phenomenon and biological 
mechanisms have been approved in current biological sciences [4-6]. Surgery might be a solution 
to certain chronic diseases, for example, implanting electrodes in the brain of Parkinson's disease 
patient to control tremble and dyskinesia [7]. However, the high cost of surgical operations and 
large risk of postoperative infection overwhelm the elderly patients who are the main group of 
chronic diseases. The most frequent therapies are regular drug and healthy behaviors of diet and 
exercise which contribute to relieving the incurable burden and improving health outcome and 
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quality of life [8,9]. Clearly, the optimal therapy for chronic diseases will be complex and require 
upgrading the health care system. However, part of the solutions may lie in how we take 
advantage of current advances in information technology to develop efficient system that is 
required to cope with the increased life expectancy. 
 The conception of mobile health appears on the scene to relieve the pressure of clinic 
management and to intervene the reinforcement of preventive medicine [10]. There have been 
many breakthroughs in monitoring system using mobile devices like mobile phone and personal 
digital assistant, which could implement electrocardiogram monitoring, diabetes control and 
dermatosis care and more [11-13]. On this sound foundation, an emerging research trend of mobile 
health places more importance on developing therapy technique which is the ultimate goal of 
wearable devices. As the developments of wireless communication and data analysis technologies, 
continuous transmission of patients' health status information to remote center can receive 
intervention from physicians and acquire complete self-management to chronic diseases [14,15]. 
Also, the approach of physical therapy including electrical stimulation, phototherapy, ultrasound 
and so on can be used to intervene the body, focus on musculoskeletal, neuromuscular, 
cardiovascular, pulmonary and integumentary disorders [16]. Besides, the miniaturization of 
equipment and the development of circulation system based on existing heavy therapeutic devices 
open a door to wearable therapy devices. Fig.1 showed the wearable monitoring and therapy 
devices throughout the body via the methods mentioned above, which feature long-term functional 
treatment to one or more kinds of chronic diseases, exploding into a prominence in the field of 
health care in the last few decades. 
 In this context, the present article aims to present a comprehensive review of the latest 
wearable devices for monitoring and therapy. In the following section, key technologies will be 
discussed which enabled the development and deployment of wearable devices for monitoring and 
therapy. The next two sections will demonstrate the examples of application of these technologies, 
while advantages and disadvantages of the specific systems will also be mentioned. Finally, 
current development and challenges will be outlined, as well as a brief outlook on future 
breakthroughs. 
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Fig. 1 Applications on wearable monitoring and therapy devices for chronic diseases 
 
2. Key enabling technologies 
Wearable devices for patients' monitoring and therapy means applying the portable and 
wearable systems to the medical field, including physiological and biochemical monitoring out of 
hospital, movement assistance, precise drug delivery, physical therapy and more. Recent advances 
in sensor technology, microelectronics, microelectromechanical system (MEMS), data analysis 
technology, telecommunication and physical therapy have enabled the development of wearable 
systems for patients' monitoring and therapy. 
 The miniaturization of electronic circuits based on the use of microelectronics has played an 
important role on the wearable devices. Looking back to history, it is not surprised to find how to 
downsize the medical equipment via a gradual process. Using electrocardiogram (ECG) as an 
example, Fig. 2 illustrates the evolution of devices from water buckets [183], bench-top [184] and 
portable sizes [185] to the recent wearable devices like belt, wrist strap and clothing [17,186,187], 
which may evolve into flexible and stretchable film with organic electronics in the next stage [18]. 
One conception closely relevant to wearable devices is the continuous monitoring and therapy. In 
the past, the size of sensors and front-end electronics made the hardware gathering physiological 
and biochemical data too obtrusive to be suitable for long-term monitoring application. Now 
developments in the field of microelectronics have allowed researchers to develop miniaturized 
circuits possessing sensing capability, microcontroller functions and radio transmission. MEMS 
has also enabled the development of miniaturization, which can realize batch fabrication reducing 
the cost of electronic components significantly. In addition, MEMS is the foundation of 
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microneedle for transcutaneous detection and drug delivery. The painless and precise 
characteristics promise microneedle large prospects in the application of wearable monitoring and 
therapy devices. 
Wearable device
Electrical skin
Original devices
Portable device
Bench-top 
device
Flexible/comfortable
Generation
Wearable device
Wearable device
 
Fig. 2 Evolution of ECG devices with the miniaturization of electronic circuits [17,18,201-205] 
 
 Wearable systems for monitoring and therapy often integrate multiple sensors into a network 
which is coordinated with other actuator and processor units by wireless communication. 
Conducting this kind of short-range information transmission inside the wearable device, 
Bluetooth is a preferable choice. As for the long-range data transmission to remote severs, an 
information gateway, which is a personal device such as smart phone or personal computer with 
powerful processors and large memory capacity, is needed to gather the physiological signals from 
the sensor network, preprocess the received data and retransmit them to a central server. Advances 
in wireless communication have enabled the remote transmission of data in a short time. There is a 
wide variety of available wireless technologies that can serve this goal. Such technologies 
including WLAN, WiMAX as well as mobile phone communication standards like 4G can offer 
wide coverage and ubiquitous network access. 
 Data management is the bridge connecting complex human bodies' parameters and specific 
healthcare services. Automatic integration of collected data or manual input into research database 
can provide the medical community or the caregiver with an opportunity to prediction of personal 
health trends, early detection of disorders, enabled insight into illness evolution, the effects of 
medicine therapy and the rehabilitation process, which help patients suffering chronic disease 
more likely to feel in control of their health as well. System may not rely on the active 
participation and intervention of the user when the closed loop between sensor network and 
actuators like pump and electrode carry out the therapy function directly. One of the major data 
obstacles to the adoption of wearable device is the massive amount of data during the long-term 
and multiple monitoring of patients' status out of hospital. Data analysis techniques such as signal 
processing, pattern recognition, data mining and other artificial intelligence-based methodologies 
have enabled the continuous monitoring that would have been otherwise impossible. Besides, 
effective algorithm to control the dynamic physiological parameters and deal with emergencies are 
also important issues. For example, smart algorithms for the closed loop insulin pump are urgently 
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needed to accomplish the proper medicine titration in various occasions including exercise, diet 
and overnight avoiding time lags in subcutaneous glucose sensing and insulin action [19]. 
 Finally, a discussion of physical therapy for wearable device in this review paper mainly 
refers to two aspects: functional trainings and physical agent therapies including electrotherapy, 
phototherapy, ultrasound therapy, magnetotherapy, compression therapy and so on. Functional 
trainings combined with wearable devices could provide physically disabled individuals due to 
neurological disorders with high intensity and repetitive training and augmented feedback to 
improve performance [20]. It is now widely accepted that the brain has the potential for neural 
repair following stroke and other injuries through neural plasticity [21]. Positive rehabilitation 
through neuroplasticity depends on the functional tasks and the number of repetitions both of 
which the wearable therapy systems can meet in our review. With regard to physical agent 
therapies, the most comprehensive applied approach is electrotherapy. Direct current therapy is 
also called transdermal iontophoresis, which uses an electric field to move both charged and 
uncharged drugs across the skin [22]. Also, reverse iontophoresis extracting glucose from the skin 
is applied in the continuous glucose monitoring and provide a foothold for artificial pancreas. 
Another electrotherapy discussed in this review is functional electrical stimulation (FES) that 
stimulates the patient's muscles by previously configured electrical impulses to generate joint 
movement as a means of gait compensation. In general, although there is not thorough and 
systematic cognition on the therapeutic mechanism of wearable devices, it remains a potentially 
useful remedy to seek for rehabilitation scheme from the basic physical methods and biochemical 
effects following up the current technologies. 
3. Wearable sensors for physiological parameters monitoring  
Physiological measures for health monitoring include body temperature, respiration rate, heart 
rate, electrocardiogram (ECG), electroencephalogram (EEG), blood pressure (BP), blood glucose, 
blood oxygen saturation (SpO2), electromyography (EMG) and muscle activity. Until recently, 
continuous monitoring of physiological parameters can only be realized in the hospital setting. 
However, the possibility of accurate, continuous and long-term monitoring of physiological 
parameters out of hospital is a reality with developments in the field of wearable technology. Here, 
we will illustrate some wearable sensors for different types of physiological parameters 
monitoring and list out their respective characteristics and issues. 
3.1 Bioelectrical signal monitoring 
The activities of human organs, such as heart, muscle, brain and so on, result in bioelectric 
signals which are defined as electric potentials between points in living cells and can be measured 
with several techniques. 
ECG is one of the most widely used bioelectrical signal and many wearable ECG systems 
have been available in the market to date. A wearable physiological monitoring system for space 
and terrestrial applications named "Life Guard" to monitor the health status of astronauts in space 
was developed by Stanford University and NASA [17], where ECG signals and heart rate were 
acquired with traditional button electrodes providing ECG Lead II and V5. Thereafter the spread 
of mobile phone and the GSM (global system for mobile communication) mobile telephony 
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network pushed the wearable ECG device with real-time telemonitoring to a new stage [23], 
which could help out-patients record their conditions for clinical analysis, emergency detection 
and effective rescue [11,24,25]. To get broader wearable application and better user experience, 
the electrode of ECG may deserve a discussion. Conventional wet ECG sensor always accounted 
for the complete market for medical use [26] but the drawbacks were also obvious that the pastes 
or gels to keep the electrical contact could cause skin irritation and discomfort. Especially when 
sweating in rigorous physical exercise, the electrodes might become loose and break electrical 
contact. Therefore, new dry-contact and noncontact electrodes through biopotential sensor 
technologies, using the skin and the electrode as the two layer of a capacitor, were researched to 
address these problems. Gruetzmann et al. [27] demonstrated a foam electrode which exhibited 
excellent stability with increased resistance to motion artifact versus the wet electrode. Park et al. 
[28] developed a wearable capacitive ECG monitoring system that did not require direct contact to 
the skin but possessed comparable performance to gold standard conventional electrodes. More 
typical nonadherent capacitive ECG sensing devices are summarized in Table 1. They could not 
only be worn by the subjects in the form of clothing, belts, watches and shoes, but also be 
embedded into ambient environment such as mattress or back of chair, bed, steering wheel of car 
and more. The major challenges of wearable ECG devices with non-adherent are the capacitive 
mismatch due to motion artifacts and the high contact impedance due to the indirect contact [29].  
EMG is a good measure of the strength of contraction of the muscle, which can be used as a 
diagnostics tool for identifying neuromuscular diseases, or as a control signal for prosthetic 
devices such as prosthetic hands, arms and lower limbs. There are two kinds of EMG: surface 
EMG and intramuscular EMG. Surface EMG is more commonly used for wearable monitoring. 
Though there is some variation in surface EMG compared with original EMG, it can response the 
pattern of muscle contraction to a certain extent and provided a lot of information for action 
recognition [30]. As EMG signals contain some undesired sources like ECG artifacts, filtering 
techniques is suggested to eliminate all the noises. However, this process may reduce the noises 
but the quality of EMG signals is not guaranteed. For real-time monitoring, the classification of 
EMG signals is an important issue [31]. Accurate hand gesture classification including the 
position and pressure of finger presses, as well as the tapping and lifting gestures across has been 
realized by using forearm electromyography [32, 33]. Anna et al. [34] presented the design of a 
wearable device for reading positive expressions from facial EMG signals. Due to the intrinsic 
issues of electrode placement, a multi-attribute decision-making was adapted to find adequate 
electrode positions on the side of face to capture these signals. Applications of this wearable 
sensor can be extended to the medical support by long-term facial expression recognition during 
therapeutic interventions. Besides, the combination of SEMG and ACC signals was demonstrated 
to have the superiority both fine subtle actions and large-scale movements [35]. Further, the 
identification of highly discriminative features has been realized by extracting information from 
the EMG signals for the automatic assistance of people instability, which could be applied in 
continuous daily activity monitoring and fall detection [36, 37].  
EEG is a non-invasive method for measuring brain activity. Compared with EMG control for 
body limbs, EEG-based brain-computer interfaces (BCI) translate brain activity into control 
signals without physical movement, which can be used as a means of communication for 
individuals with severe disabilities [49]. Though the clinical potential of enabling communication 
through an EEG BCI remains unclear, many key issues including the classification algorithms [50], 
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the acquisition of BCI control [51], psychological principles of BCI use [52], and wireless and 
wearable EEG system design [53] have been discussed. Besides BCI communication, EEG 
monitoring can be applied to automated diagnosis of epilepsy [54-56], Alzheimer’s disease [57], 
and even sleep disordered breathing [58]. Selecting features that best describe the behavior of 
EEG signals are important for automated seizure detection performance. Many time-domain [59, 
60], frequency-domain [61-66], time-frequency analysis [67], energy distribution in the 
time-frequency plane [68, 69], wavelet features [62, 70] and chaotic features such as entropies [60, 
71] are used for seizure detection.   
 
Table 1 Non-adherent capacitive ECG sensing devices 
Devices Location of ECG electrodes Measured signals References Year 
ECG Monitoring System Attached on T-shirts ECG [28] 2006 
ECG of neonates and 
infants 
Attached on underwear ECG [38] 2006 
Wearable smart shirt Attached on shirt with wireless 
network  
ECG, heart rate, 
Physical activity 
[39] 2009 
Wearable ECG sensor Integrated into a cutton 
T-shirt 
ECG [40] 2012 
Ambulatory ECG 
monitoring  
Integrated on underwear ECG [40] 2007 
Non-contact ECG/ 
EEG electrodes 
Integrated into fabric and 
clothing 
ECG, EEG [42] 2010 
ECG measurement in 
clinical practice 
Integrated into a pillow of 
a pre-ambulance bed 
ECG [43] 2009 
Sleeping bed Between the mattress and 
bed sheet 
ECG, heart rate, 
blood pressure 
[44] 2009 
Aachen smart-chair Integrated into the backrest 
and pad of a chair 
ECG [45] 2007 
Non-contact chair  
based system 
Integrated into the backrest 
of a chair 
ECG, BCG, heart 
rate, blood pressure 
[46] 2012 
Non-contacting ECG 
measurement 
Attached on toilet seat ECG [47] 2004 
Wireless steering  
wheel 
Integrated into steering 
wheel 
ECG, heart rate [48] 2012 
   
3.2 Acoustic signal monitoring 
Physiological acoustic signals from the human body include heart sounds, respiratory sounds, 
gastrointestinal sounds, limb joint sounds and more. Continuous monitoring and quantitative 
analysis of these physiological sounds are expected to play important role in the emerging 
wearable and mobile healthcare field. Here, two kinds of acoustic sensors were discussed.  
The first introduced sensor was microphone, which can be subdivided into electret, MEMS 
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and piezoelectric film microphones. Corbishley et al. [72] demonstrated a miniaturized and 
wearable system for respiratory rate monitoring. The microphone was placed on the neck to record 
acoustic signals associated with breathing, which were band-pass filtered to obtain the signal 
modulation envelope. By developing techniques to filter the noise sources and interference 
artifacts, the average success in the measurement of breathing rate had achieved 91.3%. On the 
basis of breathing rate monitoring technology, heart rate could also be extracted by placing a small 
sensor at the neck [73]. An algorithm for the segmentation of heart sounds (S1 and S2) and 
extraction of heart rate was presented to avoid the weakness of conventional method of acoustic 
signal acquisition that needed to place the sound sensor at the chest where this sound is most 
audible. The authors managed to achieve accuracy greater than 90% with respect to heart rate 
value provided by two commercial devices. Moreover, the sensing methods of joint acoustical 
emissions from the knee were also proposed in many researches [74-76]. Friction between the 
structures and articulating components of the knee joint gives rise to various kinds of vibrations, 
which can be continuously monitored by miniature microphones places on the knee for wearable 
rehabilitation assessment. Changes in joint sounds during recovery from musculoskeletal injury 
could be quantified by analyzing the consistency of the knee acoustical emission during different 
activities [75].  
Another kind of acoustic senor discussed in this article was accelerometer, which could 
detect the vibration of the skin due to sounds generated inside human body [77]. Typical 
applications of acoustic accelerometer sensors covered vocal behavior monitoring [78], heart 
sound monitoring [79], respiratory sound monitoring [80], fetal monitoring [81], and even 
gastrointestinal sound monitoring [82]. Compared with microphones, accelerometers are more 
sensitive to motion noise. Some algorithms have been developed to remove motion artifacts. For 
example, Pandia et al. [83] provided a method to effectively extract heart sound signals from 
accelerometer data overwhelmed by motion artifacts. Besides, friction noise generated between 
the sensor and the skin or clothes is also a big challenge. There a lot of methods to reduce or 
prevent friction noise including fixing the sensors to cloth, using low friction wires and slippery 
film coatings on the sensor surface and more. 
3.3 Optical signal monitoring 
Due there is not light source in human body, here we focused on the photoplethysmographic 
(PPG) sensing that involves a light-emitting diode to emit light into tissue and a photodiode to 
measure the amount of light reflected from or transmitted through the tissue. Because blood flow 
to the skin can be modulated by multiple physiological systems, the PPG can be used to monitor 
SpO2 [84], heart rate [86], respiration rate [86] and BP [87].  
In recent researches, the PPG sensors have been explored to design compact and lightweight 
for wearable measurement, which can be placed in different sites including the finger, wrist, 
brachia, earlobe, external ear cartilage, and the superior auricular region. Commercial clinical PPG 
sensors commonly use the finger, earlobe and forehead [88]. Earlobe sensors have become popular 
as pulse rate monitors because the transmitted PPG signal amplitude from the earlobe provides the 
largest perfusion value. Patterson et al. [89] introduced an ear-worn and flexible PPG sensor for 
heart rate monitoring, which is suited for long-term and continuous monitoring due to its location 
and unobtrusive design. However, over the course of a variety of daily activities like walking or 
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jogging, the PPG sensor signal may become contaminated with motion artifacts. Relatively, 
sensors based on finger measurement sites are more easily to access and acquire good signal. For 
example, to minimize motion artifacts, a double ring design was developed to reduce the influence 
of external forces, acceleration and ambient light, and to hold the sensor securely to the skin, so 
that the blood circulation in the finger remained unobstructed [90-91]. Xu et al. [92] developed a 
near-infrared phototransistor with high sensitivity based on organic bulk heterojunction, which 
showed great potential for the design of low power PPG sensor. This phototransistor can be used 
as the detection unit in a PPG sensor for continuous finger pulse wave monitoring. Besides, novel 
PPG sensors with the wristwatch-type design have also been developed. Unlike previous methods 
that obtained signals from the capillaries in the skin, this method measures the signal from the 
radial artery and the ulnar artery of the wrist. Nemati et al. [93] proposed a promising wrist watch 
with PPG sensors for atrial fibrillation monitoring, which is the first study of enough high 
accuracy for general population without an ambulatory Holter electrocardiographic monitor. 
Lastly, forehead sensors have shown greater sensitivity to pulsatile signal changes under low 
perfusion conditions, compared with other peripheral body locations [94]. The forehead structure 
including the thin-skin layer and the prominent bone helps to direct light back to the photo 
detector, showing the result of decreased motion artifacts during different physical activities.   
3.4 Biochemistry index monitoring 
Biochemical index monitoring has recently gained a great deal of interesting among 
researches in the field of wearable technology. Combined this article’s subject of chronic disease 
management, we focus the discussion on continuous glucose monitoring (CGM), which measures 
interstitial glucose as a marker of changes in blood glucose concentration, has more potential 
benefits than capillary blood glucose with point sample in the management of patients with type 1 
diabetes [95].  
The technology of CGM was introduced 15 years ago when some devices were approved by 
the U.S. Food and Drug Administration (FDA) and CE in Europe [96] for use, based on invasive 
subcutaneous sensor, minimally invasive microneedle and noninvasive methods mainly including 
transdermal and optical measurement [97]. The MiniMed (Medtronic Diabetes, Northridge, 
California) Continuous Glucose Monitoring was an invasive device using a subcutaneous 
needle-type amperometric enzyme electrode based on GOX [98,99], which was attached on the 
abdomen of patient with a fixed belt. It acquired signal every 10 seconds and saved an average of 
the signal in memory every 5 min. Potts et al. [100] combined reverse iontophoresis extracting 
glucose from intact skin with an in situ glucose sensor in a device called the GlucoWatch G2 
Biographer (GW2B, Cygnus, Redwood City, California) just like an electronic watch that was 
convenient for children to wear. Clinical researches including controlled clinical environment and 
the home environment had suggested the accuracy was relatively constant but not reliably in large 
blood glucose variation such as hypoglycemia [101, 102]. More current representative commercial 
CGM devices are provided in Table 1, with noninvasive method including ultrasonic, optical, 
electromagnetic, thermal and enzymatic sensing. It is observed that these devices are all small size, 
light weight and easy to wear. Further applications of the CGM devices may become a critical 
component of the closed loop insulin delivery system and, as such, must be selective, rapid, 
predictable and acceptable for continuous patient use [97-99]. However, three main accuracy 
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limitations of CGM technology must be improved, including the calibration in rapidly changing 
condition [103, 104], the time lag because of blood-to-interstitial glucose transport and the sensor 
processing time [105, 106], as well as the error from random noise confound CGM data 
[107-109]. 
 
Table 1 Main reported commercial CGM devices with substantiated claims 
Brand 
name 
Symphony HG1-c GlucoTrack FreeStyle Navigator 
Method Ultrasound-based 
transdermal permeation 
Raman spectroscopy Ultrasonic, thermal and 
electromagnetic sensing 
Enzyme-tipped catheter 
Country USA USA Israel USA 
Company Echo Therapeutics C8 MediSensors Integrity Applications Abbott 
Website http://echotx.com/ http://www.c8medisensor
s.com/ 
https://www.integrity-ap
ps.com/ 
http://www.abbott.com
/ 
Display 
    
Characteri-
stic 
Permeated skin 
measurement with some 
irritation [110,111], 
needing 
fast warm-up [112,113] 
Scanning the skin with 
monochromatic source 
[114] and returning 
spectroscopy having high 
discrimination for glucose 
[115,116,188] 
Attaching clip on the 
earlobe with abundant 
blood supply and not 
affected by activities 
[117,118] 
Minimally invasive 
[119], needing warm-up 
about one hour and 
providing early-warning 
about high or low 
glucose [120] 
 
3.5 Pressure signal monitoring 
Human body’s pressure monitoring is an extensive concept, ranged from the obvious daily 
activity like the foot plantar pressure [121] to the subtle signal like the vibration of pulse [122].  
In terms of daily activities monitoring, extensive research efforts have been made to access 
the accuracy of wearable sensors. Sazonov et al [123] developed an in-shoe pressure and 
acceleration sensor system for automatic recognition of postures and activities in patients with 
stroke, which could classify activities including sitting, standing and walking and detecting 
whether subjects were simultaneously performing arm reaching movements. Besides, combined 
wireless communication, the work undertaken by Bamberg et al. [124] had received much 
attention. Their device called GaitShoe developed complete wireless in-shoe system for gait 
analysis, which was capable of detecting heel-strike, estimating foot orientation and position. 
On the other hand, with the development of flexible electronics, pressure sensors have 
emerged as a highly active field due to their unique advantages of flexibility, low-cost and high 
sensitivity. The mimicry of human skin to sense pressure is a topic of innovative research. Many 
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physiological monitoring studies in this field have been made as shown in Fig. 3. Bao's team [125] 
developed a flexible pressure sensor based on organic thin film transistors and used it to monitor 
continuous radial artery pulse wave with no invasion and high fidelity. Pang et al. [126] also 
showed a flexible sensor that was based on two interlocked arrays of high-aspect-ratio Pt-coated 
polymeric nanofibres. This device has been used to measure the physical force of heart beat by 
attaching it directly above the artery of the wrist. Gong et al. [127] used ultrathin gold nanowires 
to develop wearable sensor, whose superior sensing properties in conjunction with mechanical 
flexibility and robustness enabled real-time monitoring of blood pulses. Other flexible systems 
were concentrated on human motion monitoring, such as the silk-molded pressure sensor for 
speaking recognition [128], the carbon nanotube strain sensor for movement and breathing [129], 
as well as the system including sensor, memory and actuator for diagnosis of movement disorders 
[130].  
 
Fig. 3 Flexible electronics for various physiological measurement developed by different groups: 
(a) a flexible pressure sensor for continuous radial artery pulse wave [125]. (b) a flexible sensor 
for physical force of heart beat measurement [126]. (c) a flexible sensor for real-time monitoring 
of blood pulses [127]. (d) a silk-molded pressure sensor for speaking recognition [128]. (e) a strain 
sensor for movement and breathing monitoring [129]. (f) a system for movement disorder 
diagnosis [130]. 
 
4. Typical applications for chronic disease therapy 
Based on the rapid development in monitoring systems for various physiological parameters, 
an emerging research trend of wearable system is to put more importance on developing therapy 
technique. Applications about wearable therapy devices with long-term monitoring can be divided 
into two systems, namely remote medical treatment and direct remedial treatment, while 
physiological parameters extracted from sensors can provide indicators of health status and have 
tremendous diagnostic value as well as therapeutic evaluations. Fig. 4 demonstrates a whole 
framework of remote medical treatment based on the monitoring of wearable sensors. These 
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wearable sensors deployed according to the clinical application of interest are connected to mobile 
devices to gather different physiological information regarding the status of the individual. These 
measurements are forwarded via a wireless sensor network to a central connection node such as a 
mobile phone, then to a medical center. The professional physicians in medical center will give 
intervention to patients' behaviors based on the transmitted data, which can also be shared with 
families to keep acquaintance and deal with emergency situations whenever necessary. Systems 
for direct remedial treatment also rely on the wearable monitoring, but they take therapeutic 
measures directly like drug injection, defibrillation, auditory signal stimulation and more rather 
than relay suggestion from physician and behavior feedbacks remotely. Here, aiming at the 
chronic disease therapy, we will make a discussion on some typical wearable applications by 
dividing them into different functional assistance including organ, limb as well as daily habit 
management, and then review their respective developments and existing problems. 
 
Fig. 4 Framework of telemedicine based on the monitoring of wearable sensors 
4.1 Organ function assistance 
The major hazard of chronic disease lies in the damage of vital organs like heart, pancreas 
and kidney. For patients with severe symptoms, the immediate and continuous function assistance 
of organ is very necessary when organs exhibit hormone imbalance or rhythm disorder. Wearable 
therapy devices for organ function assistance, which are also called as artificial organs, are aimed 
to timely response one or more abnormal conditions and maintain the homeostasis.     
4.1.1 Wearable cardioverter-defibrillator for heart disease 
Sudden cardiac death that mainly resulting from tachyarrhythmia is a major cause of 
mortality in industrialize populations, the rate of which in the United States, Netherlands, Ireland 
and China range from 50 to 100 cases per 100 000 in the general population annually [131]. After 
a few years of clinical investigation [132,133], the wearable cardioverter-defibrillator (WCD) that 
could provide an effective technology to improve survival rate of patients with a previous episode 
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of sudden death, left ventricular dysfunction or ventricular tachyarrhythmias [134] was approved 
and introduced into practice until two years ago.  
Currently, there are two WCD models available, the older LifeVest3100 and the new 
LifeVest 4000 [ZOLL Lifecor Corporation (ZOOL), Pittsburgh, PA, USA] [135]. Both of them 
used a chest garment to hold inplace two large posterior and one apical self-gelling 
defibrillationelectrodes, as well as four non-adhesive capacitivedry tantalum oxide 
electrodesmounted on an elastic belt for long-term ECG monitoring. The ECG-sensing electrodes 
provided two non-standardleads, front-back and left-right site bipolar ECG signals, for continuous 
electrocardiographic analysis. The three defibrillation electrodes were incorporated with a 
vibration plate to generate tactile notification as the first of a sequence of alarms once ventricular 
tachycardia or ventricular fibrillation was detected. However, the application of WCD useful for 
acute phase care is still limited according to the clinical practice [136] because it can only be a 
bridge to ICD (implantable cardioverter- defibrillator) or help avoid unnecessary ICD 
implantation. 
4.1.2 Wearable closed-loop insulin pump for diabetes 
Diabetes, with approximately 220 million diagnosed people in the worldwide [189], presents 
an indispensable problem to the health and social care systems. It is a chronic illness that requires 
continuing medical treatment and ongoing self-management to control the progression due to lack 
of permanent cure. In terms of continuing medical treatment for diabetes, insulin control of high 
blood glucose is the most effective means and the artificial pancreas that deliver extrinsic insulin 
automatically [137] has been proved a promising method.  
The artificial pancreas (AP) is made up of CGM device and insulin pump while insulin 
delivery is modulated subcutaneously according to real-time interstitial glucose levels [138]. The 
major challenge in AP closed-loop system is refining the phase processes including overnight 
control, meals control and exercise control to avoid hypoglycemia. Now the simplest form of a 
closed-loop is to suspend insulin delivery at low glucose levels. Buckingham et al. [139] used five 
predictive algorithms to realize overnight control avoiding hypoglycemia in children and young 
adults with type 1 diabetes mellitus. In the clinical trial, insulin suspension was initiated at 
normoglycemia when the glucose trend was decreasing, and this measure prevented hypoglycemia 
on 75% of nights without a rebound to hyperglycemia. Del et al. [140] developed a new modular 
MPC algorithm focusing on meal control as the rapid rise of post-meal glucose is difficult to avert 
due to the inherent delays in subcutaneous insulin absorption and action, which showed 
satisfactory dinner control versus open-loop. This system running on a smart-phone in outpatient 
conditions reduced hypoglycemia but accompanied with marginal increase in average glycemia 
resulting from a possible overemphasis on hypoglycemia safety [141]. Co-administration of 
insulin and glucagon was investigated by El-Khatib et al. [142] to control the blood glucose at 
normal range. No hypoglycemia was observed during a 24h period of day-and-night closed-loop 
delivery in 11 adults once an appropriate pharmacokinetic model of insulin absorption was used. 
The MiniMed Paradigm® REAL-Time system was launched as early as 2006, which integrated 
real-time CGM with an insulin deliver device [143]. It was small in size so patients could wear it 
almost anywhere such as under the clothing in a leg pouch or on the belt like a mobile. Insulin 
delivery and CGM were made possible through tiny components patients wear for up to six days 
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at a time [190]. Although the REAL-Time system did not automatically adjust insulin delivery 
based on sensor glucose data in its current embodiment, this integrated system formed the basic 
platform for further generations of products in which the sensor will modify insulin dosing in 
semi- and ultimately fully closed-loop modalities. 
4.1.3 Wearable artificial kidney for chronic kidney disease 
A wearable artificial kidney (WAK) is a long-held aim in the treatment of patients with 
chronic kidney disease, provided that it would combine continuous blood purification, preventing 
the fluctuations and complications in intermittent dialysis for three time a week normally 
[144,145]. Though the WAK is not commercialized owing to some technical problems, numerous 
efforts has been carried out for decades and the breakthroughs and the issues are summarized in 
Table 2. Treatment modalities of dialysis includes hemodialysis (HD), hemofiltration(HF) and 
peritoneal dialysis (PD), while all three need to minimize the huge dialysate supply system to 
realize wearability and portability [146]. Pioneers proposed the concept that continuous 
regeneration and reuse of a small amount of dialysate in a closed-loop system instead of using 
large volumes of dialysate in a single pass configuration as done in conventional dialysis. Kolff et 
al. [147,148] provided a portable WAK system consisted of pumps, batteries, dialyzers and a 
charcoal regeneration cartridge, where 20 l of dialysate tank was attached for 1.5-2h for urea and 
potassium removal. Due to large dialysate volume for electrolyte balance, it was portable rather 
than wearable. Murisasco et al. [149,150] developed a more advanced regeneration module based 
on the combination of sorbents and enzyme which was called recirculating dialysis (REDY) 
system. This cartridge used for purifying the dialysate included urease for removal of urea, 
charcoal for absorption of non-urea organic toxins, zirconium phosphate for removal of potassium 
and ammonium, and zirconium oxide for removal of phosohate. However, a large amount of 
zirconium phosphate required to remove the generated ammonium limits further miniaturization. 
After that, more different approaches were tried. Gura et al. [151,152] developed a belt-type 
wearable HD machine that can accomplish dialysate regeneration with 375 ml of dialysate volume 
and got acceptable clinical results. However, this device had some limitations such as inaccurate 
electrolytes, acid–base control and ammonium accumulation in the sorbent cartridge. It is to be 
observed that the PD as a blood-free dialysis technique can be an alternative to HD and HF 
approaches. Roberts et al. [153] proposed a concept of tidal PD using a hemofilter and REDY 
sorbent cartridge for WAK. But at that time, an appropriate double-lumen PD catheter was not 
available and the safety of sorbent cartridge was not properly verified in clinical. Ronco et al. [154] 
showed the concept of a wearable device called ViWAK based on sorbent cartridge technology 
and double-lumen PD catheter. Although this device was not applied in clinical trials, the main 
innovation was the remote control with a handheld computer. The common disadvantage of PD 
was an addition of an injection system for glucose and bicarbonate to maintain acid-base balance 
and osmotic force. 
 
 
 
- 15 - 
 
Table 2 Historic view on wearable artificial kidney 
Name TM Technology 
breakthrough     
Issues Clinical 
Experiment 
Year
s 
Ref. 
Portable WAK HD A charcoal 
regeneration cartridge 
Large dialysate 
volume 
5 patients, 3h , 
6 times per week 
1976 [147,148] 
Continuous 
Hemofiltratiom 
HF Sorbent and enzyme 
technology (REDY) 
Large amount of 
zirconium 
phosphate 
2 patients, one for 1 
month and another 
for 1 month 
1986 [149,150] 
Flow-thru  
PD 
PD Concept of tidal PD, 
REDY sorbent 
cartridge 
Additional injection 
system for glucose 
and bicarbonate 
Before clinical 1999  [151] 
The WAK HD Pulsatile pump, 
REDY sorbent 
cartridge 
Variation of 
composition and 
PH in dialysate 
8 patients for 4-8 h 2007 [152] 
ViWAK PD Remote control, 
double lumen PD 
catheter 
Variation of 
composition and 
PH in dialysate, 
glucose injection 
Before clinical 2007 [153] 
The WHF HF Pulsatile pump, 
improved middle 
molecule clearance 
Low small solute 
clearance 
6 patients for 6h 2008 [155] 
 
4.2 Limb function assistance 
The aim of wearable therapy devices applied on limb function assistance is to facilitate the 
patient’s task performance after a neurological injury. Without these wearable devices, training 
based on manual assistance is exhausting for the staff, and the duration of training is thus limited 
by the fatigue of the therapist. Besides, the manual assistance is lack of the repeatability of 
training and quantitative evaluation of curative effect. These disadvantages can be relieved or even 
overcome with the use of wearable therapy devices. 
4.2.1 Therapy of Parkinson's disease based on symptoms monitoring 
Parkinson's disease is a common neurodegenerative disorder caused by a deficiency of 
dopamine due to the severe neuronal dysfunction in the substantia nigra pars compacta [156], 
which affects about 3% of the population over the age of 65 years and more than 500,000 U.S. 
residents [157]. Current therapy is mainly based on pharmacotherapy using the biosynthetic 
precursor levodopa or drugs to activate dopamine receptors, which just maintains effective for 
some time but eventually develop complications like motor fluctuations and psychiatric 
disturbances.  
    Another key factor reducing the patients' quality of life is motion problems such as tremor, 
freezing of gait, postural instability. It is well recognized that auditory, visual or tactile stimuli can 
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improve gait in patients with Parkinson's disease. As a result, devices that exploit the sensory 
cueing-related modification of gait in patients have been proposed. Bachlin et al. [158] developed 
a wearable system with acceleration sensors to detect freezing of gait (FOG) and provided a 
rhythmic auditory signal to stimulate the patients to resume walking. The signal that 1Hz ticking 
sound starting whenever a FOG episode is identified and ending when the patient resumes walking, 
verified that discontinuous and selective external cueing can keep the effect to improve the gait 
stability. Ferrarin et al. [159] demonstrated a pair of optical stimulating glasses that provided 
different types of continuous optic flow and intermittent stimuli synchronous with external events. 
After prolonged testing, the device showed a remarkable increase in stride length for all subjects. 
Espay et al. [160] examined the efficacy of a closed-loop wearable visual-auditory cueing device 
in 13 patients with Parkinson's disease with off-state gait impairment. After 2 weeks of twice daily 
use at home, an overall improvement in gait was measured. 
4.2.2 Wearable rehabilitation robots in neurologic injuries 
Wearable robots known as robotic exoskeleton and powered orthoses are being developed for 
movement disabilities caused by neurologic injuries like stroke, traumatic brain and spinal cord 
injuries [161,162]. Positive outcome of physical rehabilitation depends heavily on functional 
task-oriented training that can be realized by mechanical and electrical devices with high-intensity 
and repetitive training.  
Traditionally, actuators of the devices are provided in three forms: electric current, hydraulic 
fluid or pneumatic pressure. The electrical actuators are most common because of their ease to 
provide and store electrical energy as well as their relatively higher power. Hasegawa et al. [163] 
introduced an exoskeleton assistive hand that supports human hand and wrist activities by using 
user's bioelectric potential to control movement. Rocon et al. [164] proposed an exoskeleton for 
tremor assessment and suppression with DC motors actuator as shown in Fig. 5(a). Powered 
orthosiswith electric motors controlled by joint angle were also developed to assist elbow 
rehabilitation or foot drop gait [165,166]. Pneumatic artificial muscle was used in upper extremity 
therapy robot [167] and soft robotic device for ankle foot rehabilitation [168], while its weight was 
generally light compared to other actuators but also have slow and non-linear dynamic response. 
Fig. 5(b) demonstrated the prototype of soft robotic device for ankle foot rehabilitation. 
Miniaturized and flexible fluidic actuators were applied in the elbow orthosis proposed by 
Pylatiuk et al. [169]. Moreover, another specific electrical stimulation known as functional 
electrical stimulation (FES) is the natural actuator of body muscles instead of traditional external 
actuators. From a therapeutic point of view, FES allows patients to exercise muscle and preventing 
muscular atrophy [170]. However, disadvantages are also related to the appearance of muscle 
fatigue and the control of joint trajectories [171]. Two systems combining FES with assistive force 
were proposed by Freeman et al. [172] and Li et al. [173]. There were also some commercial 
systems using FES for limb rehabilitation: H200 (Bioness, US) for hand paralysis, L300 (Bioness, 
US) for foot drop and NeuroMove (Zynes Medical, US) for stroke. Fig. 5(c) demonstrated the 
Bioness H200 system [191] including the stimulator and the control unit and the procedure that 
using this device to realize grasp. Patients could control stimulation to their hand by using the 
unaffected hand to press buttons on the separate control unit. The press of a button activated hand 
extensors and another button press turned off extensors and activated flexors. 
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Fig. 5 Wearable robotic exoskeleton and powered orthoses for limb rehabilitation: (a) wearable 
orthosis with electrical actuator [164]. (b) wearable robotic device with pneumatic actuator [168]. 
(c) The Bioness H200 based on FES as natural actuator of body muscles [191]. 
4.3 Daily habit management assistance 
Patients with chronic health conditions struggle with multifaceted needs that change during 
the course of their disease journeys. One path for the development of wearable devices may lie in 
patient-driven health care, which encourages greater patient-physician collaboration, expands 
patient social networks and increases patient use of personal data for tracking their health status. 
Through establishing the validity of data gathering, wearable monitoring devices can make a 
direct and real-time impact on daily habit management assistance. Here, taking diabetes as an 
example, we will discuss the specific management details and the latest advances.  
The diabetes’ self-management tasks such as blood glucose monitoring, physical exercise and 
diet are inherently data intensive, requiring acquisition, storage and analysis of large amounts of 
data on a regular basis [174]. One way that has been proposed to help individuals better manage 
their diabetes is to make full use of smart-phone technology, which is coupled with the 
proliferation of data connectivity and relatively inexpensive cost. El-Gayar et al. [175] reviewed 
16 articles and 71 applications and divided the features of app functions into two classes. The 
primary features included blood glucose monitoring, medication, diet management and physical 
exercise. To form a long-term record and get professional analysis from health care provider, 
some apps needed patients enter manually into the mobile phone and others realized data entry 
automation just for blood glucose through blue-tooth [176]. The second features included weight, 
blood pressure, education, alert, decision support and social networking. It was important to note 
that decision support which mainly referred to automated analysis and ruled-based interpretation 
of data on an individual basis was a comprehensive but crucial part of diabetes management. 
However, only one of the 71 applications that provided decision support had Food and Drug 
Administration (FDA) clearance in order to provide safety and assurance. DiabeteManager 
coming from WellDoc
TM 
initially, which was the only one example with FDA approval, had both 
clinical and marketable validation. WellDoc published some clinical results that documented the 
positive impact of their multipronged approach to patient and physician satisfaction [177,178]. 
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Last year, the company launched new paid application called BlueStar which received approval 
for reimbursement as a pharmacy benefit for employees of several large companies including Ford 
Motor Company, RiteAid and Dexcom [179]. The BlueStar platform still required a physician 
prescription which could reduce the cost of physician-patient communication and partly account 
for the trust of patients on the support decision. In general, management system based on mobile 
phone is designed to make patients more acquainted with their own physical conditions and more 
responsible for their own day-to-day care. 
 
5. Conclusions  
The aim of this article is to provide an overview on current status and future prospects about 
the research and development of wearable devices related to chronic diseases therapy. For this 
goal, it is necessary to define the field of wearable systems. These systems can be divided into two 
categories, namely long-term monitoring of physiological signals, as well as continuous therapy 
including organs, limbs and daily habits assistance. 
 Long-term or continuous wearable monitoring systems with unobtrusive sensors took in 
many advanced technologies like the electronic circuit, MEMS and nanotechnology, as well as 
novel approaches like noncontact ECG and glucose monitoring through blood substitutes. On this 
basis, information technology expedited the treatment with pharmaceutical products becoming 
more accurate with continuous automatic processes to dispense an effective dose of drug to treat 
disease, whose ultimate target is to replace defective organs. In the meantime, we have also 
witnessed a growing interest for the emerging need for establishing a telemedicine in the home 
setting to realize self-management and implement clinical interventions. Besides, the scope of 
chronic disease treatment through wearable devices is broadened as the miniaturization of therapy 
equipment and clinical rehabilitation evidences with attempting various remedy methods. 
 However, most systems are still in their prototype stages and there remain many problems to 
be solved. Firstly, battery technologies appears to be perhaps the biggest technical issue and 
performance bottleneck in current wearable devices that should maintain operating for long 
periods and avoid replacing and charging frequently. Low-power transceivers and power 
scavenging are supposed to be developed as quickly to reduce energy consumption. Secondly, 
security of private information about the patient's health status must be taken into account. Proper 
encryption and identity verification are needed to ensure the privacy of all communicated data in 
telemedicine. Lastly, clinical experiments to prevent infection and inflammation for some invasive 
or minimal invasive wearable systems should be done. Developed systems must be exhaustively 
tested and validated by professional physicians. 
There is plenty of room for further technological developments in wearable systems. Here, 
we envision the following emerging directions for wearable monitoring and therapy devices 
worthy of being emphasized in the near future. 
 First of all, flexible electronics, where electronic circuits are manufactured on flexible 
substrates such as paper, cloth fabrics and directly on human body to provide sensing, powering 
and interconnecting functions, have a broad range application like smart textile and transcutaneous 
film as new wearable monitoring systems. It is worth mentioning that, rapid advances in this field 
promise to allow one to print a full circuit on fabric or skin and new materials like liquid metal 
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[180] have the potential to directly print on skin to take effect. In addition, tissue engineer 
technology could contribute to mimicking physiological function of body organs. Researchers 
have suggested the concept of a renal assist device with cartridges containing human tubular cells 
[181,182], more studies should be done in vitro or vivo to enlarge the function of wearable even 
implantable system. In the end, business models of wearable monitoring and therapy devices need 
to be established. Only the wearable devices are used and accepted by patients as a reliable, 
multifunctional and easy-to-use technology, can they relieve the severe burdens of medical system 
and go farther in the avenue of improving quality of life. 
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